Making It Work: State Leadership on Medicare Rx Implementation and Coordinating with State Pharmacy Assistance Programs

Similar documents
Lessons from Implementation of Medicare Rx Discount Cards in State Pharmacy Assistance Programs and Implications for Part D

Medicare Prescription Drug Congress. MMA and Medicaid. Gale Arden Director, Disabled & Elderly Health Programs Group CMSO CMS.

Medicare Modernization Act and Medicare Part D: Status of Implementation

State Pharmacy Assistance Programs: Additional Charts

The Pharmacy Coverage Safety Net: Variations in State Responses to Supplement Medicare Part D

Alternative Paths to Medicaid Expansion

Rural Policy Brief Volume 10, Number 8 (PB ) April 2006 RUPRI Center for Rural Health Policy Analysis

Coordinating the Medicare Modernization Act with State Pharmacy Assistance Programs: A State-Level Perspective

Medicare and Patient Assistance

Medicare Part D in 2018: The Latest on Enrollment, Premiums, and Cost Sharing

Stand-Alone Prescription Drug Plans Dominated the Rural Market in 2011

Medicaid in an Era of Change: Findings from the Annual Kaiser 50 State Medicaid Budget Survey

Obamacare in Pictures

Presented by: Matt Turkstra

2017 Plan Decision Guide Your guide to making an informed Medicare Part D choice

WELLCARE WINS BID IN EVERY REGION FOR 2007 AND INTRODUCES CLASSIC PLAN WITH LOWER PLAN PREMIUMS

The State of Children s Health

Aetna Medicare 2013 Benefits at a Glance

James G. Anderson, Ph.D. Purdue University

The Affordable Care Act (ACA)

Value Choice. Summary of Benefits. January 1 December 31, 2014 S5660 & S5983. Y0046_B00SNS4B Accepted

Percent of Employees Waiving Coverage 27.0% 30.6% 29.1% 23.4% 24.9%

Medicare Part D Prescription Drug Benefit For Agent Use Only

Implementing the Medicare Drug Benefit. Robert Donnelly Director, Medicare Drug Benefit Group June 8, 2005

WORKING WITH PRIVATE SECTOR PARTNERS TO MAXIMIZE MEDICARE SAVINGS PROGRAM AND PART D ENROLLMENT

Medicaid s Future. National PACE Association Spring Policy Forum. MaryBeth Musumeci

ACA and Medicaid: Current Landscape and Future Outlook

In addition, MCHCP is requesting information about any programs or plans in place for non-medicare retirees.

FINDINGS FROM THE KAISER/HEWITT 2006 SURVEY ON RETIREE HEALTH BENEFITS

CHAPTER 1. Trends in the Overall Health Care Market

SCHIP Reauthorization: The Road Ahead

Obamacare in Pictures. Visualizing the Effects of the Patient Protection and Affordable Care Act

The Medicaid Landscape

2016 Plan Decision Guide Your guide to making an informed Medicare Part D choice

$225,000 Premium / $0 Deductible. $98,000 Premium / $0 Deductible. $110,000 Premium / $0 Deductible

Medicare Part D. What Pharmacists Need to Know to Navigate Through 2006 and Beyond

Medicare Index Report: Annual Enrollment Period for 2019 Coverage

Explaining the State Integrated Care and Financial Alignment Demonstrations for Dual Eligible Beneficiaries

An Update on Commercial Exchanges. Myra Weisfeld, Senior Managing Consultant

How to Assist Beneficiaries Impacted by Aetna/Coventry 2015 Part D Plans

Medicare Part D In Massachusetts: Successes and Continuing Challenges. Cindy Parks Thomas Massachusetts Health Policy Forum May 30, 2007

Part D: The New Medicare Prescription Drug Law Implications for Medicaid

Medicaid Expansion and Section 1115 Waivers

MARKET TRENDS: MEDICARE SUPPLEMENT. Gorman Health Group, LLC

Medicare Alert: Temporary Member Access

The Impact of Health Reform s State Exchanges

Formulary Access for Patients with Mental Health Conditions

(PDP) 2015 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard)

Robin Rudowitz, Associate Director, Kaiser Commission on Medicaid and the Uninsured The Henry J. Kaiser Family Foundation

Marilyn Tavenner, CMS Administrator Don Moulds, Acting Assistant Secretary for Planning and Evaluation

simple. secure. savings.

2014 SUMMARY OF BENEFITS

Presented by: Daniel J. Prescott Regional Senior Vice President

Closing the Coverage Gap Medicare Prescription Drugs are Becoming More Affordable

An Advocate s Guide to AIDS Drug Assistance Program (ADAP) & Medicare Part D: Understanding the Decisions Every Program Must Make

Supreme Court Ruling on the Affordable Care Act (ACA): Overview & Implications

Introducing LiveHealth Online

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018

Medicare. Medicare? What does it have to do with me? Alan Farkas, M.S., R.Ph.

Q INVESTOR PRESENTATION. May 4, 2018

Figure 1. Medicaid Status of Medicare Beneficiaries, Partial Dual Eligibles (1.0 Million) 3% 15% 83% Medicare Beneficiaries = 38.

Cost and Coverage Implications of the ACA Medicaid Expansion: National and State by State Analysis

Medicaid Funding and Policies Is There a Medicaid Crisis? A Financial Diagnosis for State and Local Government

SCHIP: Let the Discussions Begin

Experts Predict Sharp Decline in Competition across the ACA Exchanges

(PDP) 2016 Summary of benefits for our Medicare prescription drug plans (Standard and Enhanced)

Medicare: Changes, Challenges, and Opportunities for Grantmakers

A Blue Cross and Blue Shield Association Presentation

IOM Workshop The Impact of the Affordable Care Act on U.S. Preparedness Resources and Programs

Web Briefing for Journalists: Marketplace Open Enrollment in the Trump Era. Presented by the Kaiser Family Foundation October 18, 2017

Patient Protection and. Affordable Care Act: The Impact on Employers

Healthcare Reform. North Carolina Dietetic Association September 12, Duke Medicine

2008 Medicare Part D: Pharmacist's Survival Guide. Ronnie DePue, R.Ph., CGP

2019 Plan Decision Guide Your guide to making an informed Medicare Part D choice

Q4 AND FULL-YEAR 2017 INVESTOR PRESENTATION. February 23, 2018

Closing the Coverage Gap Medicare Prescription Drugs Are Becoming More Affordable

MEDICARE PART D SPOTLIGHT

Florida s Medicaid Choice: Options and Implications

Medicare Part D: TrOOP (True Out-Of-Pocket) Costs

Patient Protection & Affordable Care Act

Medicare Minute Teaching Materials - June 2018 How to Afford Your Part D Drug Costs

Medicare Part D Task Force Statement of Purpose Revised 7/12/05

Pharmaceuticals: Can or Should We Do Anything About Rising Drug Costs? Caroline F. Pearson

The Affordable Care Act and it s Impact on Employers

2018 Plan Decision Guide Your guide to making an informed Medicare Part D choice

MEDICARE PRESCRIPTION DRUG LEGISLATION: Part D Benefits and Employer Subsidies. December 2003

Medicare Part D Drug Benefit and HIV/AIDS Care. Mary R. Vienna Deputy Director, HRSA/HAB/DTTA Rockville, Maryland

Medicare Part D What s new for 2018?

PRODUCER ANNUITY SUITABILITY TRAINING REQUIREMENTS BY STATE As of September 11, 2017

Medicaid 101 Damon Terzaghi Senior Director NASUAD

Q Investor Presentation. November 2, 2018

Medicaid and CHIP Eligibility, Enrollment, Renewal, and Cost Sharing Policies as of January 2018: Findings from a 50-State Survey

Understanding the Bidding Process

Exhibit 1. The Number of Uninsured Adults Dropped to 29 Million in 2014, Down from 37 Million in 2010

Exhibit 1. The Impact of Health Reform: Percent of Women Ages Uninsured by State

Medicaid 1915(c) Home and Community-Based Service Programs: Data Update

Click to edit Master title style

CHARTPACK. Medicaid and its Role in State/Federal Budgets & Health Reform

Medicaid Home and Community-Based Services Programs:

Health Care Costs in Retirement

Transcription:

Making It Work: State Leadership on Medicare Rx Implementation and Coordinating with State Pharmacy Assistance Programs Presentation to the National Conference for State Legislatures Kimberley Fox, Senior Policy Analyst Rutgers Center for State Health Policy August 17, 2004

Goals of Presentation Briefly describe how State Pharmacy Assistance Programs (SPAPs) compare and contrast with Medicare Part D benefit and low-income subsidies. Discuss supplemental Part D options being considered by states and lessons learned from coordination with Medicare discount cards that might inform Part D implementation. Identify and discuss challenges ahead and policy changes that may be required of states going forward.

Acknowledgement Presentation based on study of state pharmacy assistance programs funded by The Commonwealth Fund. Study design Longitudinal survey of SPAPs, 2000-2003. In-depth case studies of eight subsidy programs and six state discount cards in 2002/2003. Telephone interviews in Spring 2004 with 17 states re: Medicare coordination of benefit issues and discount card experience. Website with more detailed reports: http://www.cshp.rutgers.edu/

How Many States Have SPAPs? No program enacted or operational Program enacted but not operational Program is operational Source: Trail T, Fox, K, Cantor, J, Silberberg, M, Crystal, S. State Pharmacy Assistance Programs: A Chartbook. Commonwealth Fund, New York, NY, publication forthcoming. Data from National Conference of State Legislatures web site: State Pharmaceutical Assistance Programs, 2003 Edition, http://www.ncsl.org/programs/health/drugaid.htm. August 27, 2003.

How SPAP Income Eligibility Compares with Medicare Part D and Low-Income Subsidies? 600% 500% 400% Percent of FPL 300% MMA Low-Income Subsidy Level 1 200% 150% 100% 0% MA RI NY NJ NV IL CT VT DE MI NC MO PA ME SC IN KS FL MN MD WY Source: Trail, T., Fox, K., Cantor, J, Silberberg, M., Crystal, S. State Pharmacy Assistance Programs: A Chartbook. The Commonwealth Fund, New York, NY, Publication forthcoming.

How SPAPs Compare with Part D and Low-Income Subsidies? Only 2 states have asset tests (MD,MN). Cost-sharing varies by state*, but is generally lower than cost-sharing required for non-catastrophic Basic Part D coverage. Medicare Part D low-income subsidies generally provide coverage equivalent or better than that provided by SPAPs. Medicare drug formularies likely to be more limited than most SPAPs, with the exception of a few states that limit coverage to drugs for certain conditions (6) or that have PDLs (6). Medicare private pharmacy networks are likely to be more limited than SPAPs. * For more details see: http://www.cmwf.org/programs/child/trail_spap_chtbk_758.pdf

Part D Impact on State Pharmacy Assistance Programs and Enrollees - Significant short-term savings from the $600 discount card credit if people enroll. - Huge federal $ offset under Part D particularly for enrollees eligible for low-income subsidies to the degree that people enroll. - Savings need to offset potential loss of SPAP-level rebates and administrative costs related to coordination of benefits. - The provision that allows SPAP contributions to count toward enrollees out-of-pocket costs will help enrollees get to the more generous catastrophic benefit sooner. Excludes 1115 waiver states (FL,SC,IL,WI,VT, MD). - In states that limit drug coverage to certain conditions, expanded benefits for enrollees because more drugs are covered.

SPAP Future Plans Coordinating with Medicare Rx Benefit Most SPAPs plan to continue some low-income drug coverage in 2006. Still considering Part D options; most states focusing on coordinating with Medicare discount cards in 2004. Options for 2006 being considered include: Paying all or portion of premiums. Wrapping around cost-sharing to current state cost-sharing. Providing coverage during the donut-hole (e.g. Missouri). Wrapping around formularies. Covering out-of-network pharmacies Few states had considered lump sum payment option.

Anticipated Challenges for SPAPs in Coordinating with Part D Enrollment Challenges Getting SPAP enrollees to voluntarily enroll. Gathering asset information to determine eligibility for low-income subsidies. For SPAPs that are managed by departments other than the Medicaid agency, conducting eligibility determination through Medicaid may be further deterrent for SPAP enrollees. Coordination of Benefit Challenges Developing different coordination plans for enrollees in basic Part D, in the sliding scale subsidy program, and in the lowest-income subsidy program Real-time information sharing on who is enrolled in each benefit, tracking deductibles, out-of-pocket costs, etc. Number of plans increases complexity and administrative costs. Point-of-sale duplicate billing and enforcement. Coordinating sliding scale premium and cost-sharing payments with CMS.

SPAP Experience Coordinating with Medicare Drug Discount Cards Percent of SPAP Enrollees Eligible for $600 Credit on Medicare Discount Cards 100% 80% 60% 40% 20% 0% KS MN IN MI NC MO PA CT NV RI MA NY NJ WY IL* ME TOTAL Source: Fox, K, Crystal, S. Coordinating Medicare Prescription Drug Benefits with State Pharmacy Assistance Programs. New York, NY; The Commonwealth Fund, publication forthcoming.

Few States Mandating Enrollment in Discount Cards Number of States Mandating Enrollment in Medicare Discount Cards for <135% FPL, June 2004 # of States 16 14 12 10 8 6 4 2 0 Mandatory Voluntary Source: Fox, K, Crystal, S. Coordinating Medicare Prescription Drug Benefits with State Pharmacy Assistance Programs. New York, NY; The Commonwealth Fund, publication forthcoming.

More than Half of SPAPs Working with a Preferred Discount Card and/or Autoenrolling 16 14 12 # of States 10 8 6 4 2 0 Autoenrollment in Preferred Card Facilitated Enrollment in Preferred Card Autoenrollment in Multiple Cards Voluntary Enrollment N=10 Source: Fox, K, Crystal, S. Coordinating Medicare Prescription Drug Benefits with State Pharmacy Assistance Programs. New York, NY; The Commonwealth Fund, publication forthcoming.

Vast Majority of TA Eligible SPAP Enrollees Will be Autoenrolled % of Total SPAP TA Eligible Enrollees 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% State Will Autoenroll Enrollee Must Voluntarily Enroll Source: Fox, K, Crystal, S. Coordinating Medicare Prescription Drug Benefits with State Pharmacy Assistance Programs. New York, NY; The Commonwealth Fund, publication forthcoming.

Other Incentives Employed by SPAPs to Encourage TA Enrollment 9 8 7 6 5 4 3 2 1 0 State pays all coinsurance Wrap 5-10% Copay SPAP Fee Waived $600 toward deductible Increased SPAP Benefit Cap SPAP pays first N=12 Source: Fox, K, Crystal, S. Coordinating Medicare Prescription Drug Benefits with State Pharmacy Assistance Programs. New York, NY; The Commonwealth Fund, publication forthcoming.

Coordination Lessons from Discount Card and Other State COB Efforts The more plans, the more difficult to coordinate benefits. States achieve greatest savings from working with a preferred card. Administrative hassles could deter states from providing gap-filling coverage. Coordination of benefits should be designed to minimize crowd-out of current state contributions. Autoenrollment efficient mode for getting people enrolled. Transparent to enrollees. Nearly 80% of enrollment in transitional assistance is due to SPAP and M+C autoenrollment

Coordination Lessons from Discount Card and Other State COB Efforts For states that wrap-around the 5-10% in the discount card, or that currently allow wrap of less generous rx benefits, requires considerable cooperation from pharmacists. Duplicate billing by pharmacies. May require additional audits/oversight by states to enforce. Need to identify alternative approaches (SPATC Commission?). Coordination requires accurate, timely information sharing that is best centralized by CMS rather than obtained from individual card sponsors. States that pursue third party recoveries have found that even with strict statutes, not easy to get information from private insurers and have had to pay brokers to collect information.

State Policy Decisions in 2005 - Mandatory versus voluntary - Whether to autoenroll (if allowed) and passing authorized representative legislation. - Working with multiple plans or preferred (if allowed) - Capitation or Wrap-around - What to wrap-around? - Premiums and cost-sharing - Formularies and networks (comparability issues for duals) - Concerns re: whether wrapping around formularies and networks may result in PDPs further limiting their plans.

Commenting on Part D Regulations: Some Issues of Concern for SPAPs - Comments on Part D regulations due October 4, 2004. - Non-discrimination clause and ability to work with a preferred plan. - Specifying states as authorized representatives and allowing them to autoenroll. - Minimizing documentation requirements of asset tests. - Allowing SPAPs to determine low-income subsidy eligibility - Rebate collections during donut hole period if SPAP chooses to wrap-around benefit. - Defining PDP Information requirements with SPAPs explicitly in regulations, e.g. notifying SPAPs of formulary changes. - Defining CMS Information-sharing requirements with SPAPs.